The Michigan Collaborative for Type 2 Diabetes (MCT2D) provides resources, clinical decision aids, and guidance for managing type 2 diabetes.
The Michigan Collaborative for Type 2 Diabetes (MCT2D) is a statewide quality initiative sponsored by Blue Cross Blue Shield of Michigan. The collaborative focuses on improving guideline-directed medical therapy and outcomes for individuals with type 2 diabetes across Michigan.
MCT2D offers comprehensive clinician decision aids, medication financial assistance program guides, and user manuals to support both healthcare providers and patients in navigating diabetes care and treatment options effectively.
Selected manuals from manuals+ curated for this brand.
Common questions about manuals, registration, and support for this brand.
MCT2D (Michigan Collaborative for Type 2 Diabetes) is a statewide quality collaborative aiming to improve guideline-directed medical therapy for type 2 diabetes by enrolling physician organizations and practices.
Support for MCT2D is provided by Blue Cross and Blue Shield of Michigan and Blue Care Network as part of their Value Partnerships program.
MCT2D provides a Medication Financial Assistance Programs User Guide that helps patients and providers identify manufacturer assistance programs for medications like Farxiga, Trulicity, Ozempic, and others.
Yes, while MCT2D offers specific clinician decision aids for healthcare providers, they also provide accessible resources, community connection tools, and financial guides directly for patients.